Safety, immunogenicity of lyophilized purified vero cell cultured rabies vaccine administered in Zagreb and Essen regimen in post-exposure subjects: A post-marketing, parallel control clinical trial

References

• Hampson K, Coudeville L, Lembo T, Sambo M, Kieffer A, Attlan M, Barrat J, Blanton JD, Briggs DJ, Cleaveland S, et al. Estimating the global burden of endemic canine rabies. Plos Neglect Trop D. 2015;9(4):e0003709. doi:10.1371/journal.pntd.0003709.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Rabies vaccines: WHO position paper-April 2018.
   Google Scholar
• Yao H, Yang Y, Liu K, Li X, Zuo S, Sun R, Fang L-Q, Cao W-C. The spatiotemporal expansion of human rabies and its probable explanation in Mainland China, 2004-2013. Plos Neglect Trop D. 2015;9(2):e0003502. doi:10.1371/journal.pntd.0003502.
   PubMed Web of Science ®Google Scholar
• Zhou H, Vong S, Liu K, Li Y, Mu D, Wang L, Yin W, Yu H. Human rabies in China, 1960-2014: a descriptive epidemiological study. Plos Neglect Trop D. 2016;10(8):e0004874. doi:10.1371/journal.pntd.0004874.
   PubMed Web of Science ®Google Scholar
• Fang Y, Chen L, Liu MQ, Zhu ZG, Zhu ZR, Hu Q. Comparison of safety and immunogenicity of PVRV and PCECV immunized in patients with WHO category II animal exposure: a study based on different age groups. PLoS Negl Trop Dis. 2014;8(12):e3412. doi:10.1371/journal.pntd.0003412.
   PubMed Web of Science ®Google Scholar
• Wang C, Zhang X, Song Q, Tang K. Promising rabies vaccine for postexposure prophylaxis in developing countries, a purified vero cell vaccine produced in China. Clin Vaccine Immunol. 2010;17(4):688–90. doi:10.1128/CVI.00433-09.
   PubMedGoogle Scholar
• Wang L, Sun M, Zhang X, Suo L, Xu R, Zou Y, Zuo L-B, Qi H. Safety and immunogenicity of two freeze-dried Vero cell rabies vaccines for human use in post-exposure prophylaxis. Vaccine. 2011;29(15):2679–81. doi:10.1016/j.vaccine.2011.01.053.
   PubMed Web of Science ®Google Scholar
• Shi N, Zhang Y, Zheng H, Zhu Z, Wang D, Li S, Li Y, Yang L, Zhang J, Bai Y, et al. Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects. Hum Vacc Immunother. 2017;13(6):1338–45. doi:10.1080/21645515.2017.1279770.
   PubMed Web of Science ®Google Scholar
• Hampson K, Cleaveland S, Briggs D. Evaluation of cost-effective strategies for rabies post-exposure vaccination in low-income countries. PLoS Negl Trop Dis. 2011;5(3):e982. doi:10.1371/journal.pntd.0000982.
   PubMed Web of Science ®Google Scholar
• China Food and Drug Administration. The standard guidelines for adverse reactions grading of vaccine clinical trials. 2005.
   Google Scholar
• WHO Position Paper on rabies vaccines. Wkly Epidemiol Rec. 2010;85:309–20.
   Google Scholar
• WHO Expert Committee on Rabies. Guide for post-exposure treatment. Eighth report. WHO technical report 824. Geneva Switzerland: World Health Organization 1992.
   Google Scholar
• Rupprecht C, Briggs D, Brown C, Franka R, Katz SL, Kerr HD. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices. MMWR Recommendation Rep. 2010;59:1–9.
   PubMedGoogle Scholar
• Liu H, Huang G, Tang Q, Li J, Cao S, Fu C, Cao Q, Liu B, Pan H, Wang M, et al. The immunogenicity and safety of vaccination with purified Vero cell rabies vaccine (PVRV) in China under a 2-1-1 regimen. Hum Vaccin. 2014;7(2):220–24. doi:10.4161/hv.7.2.14003.
   Google Scholar
• Wang J, Luo F, Feng Z, Li L, Bai Y, Ai X, Ma J, Zhang Z, Shi N. Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above. Hum Vaccin Immunother. 2017;13(1):144–50. doi:10.1080/21645515.2016.1230260.
   PubMed Web of Science ®Google Scholar
• Joseph J, Khan NS, Khan AM, Rajoura OP. Determinants of delay in initiating post-exposure prophylaxis for rabies prevention among animal bite cases: hospital based study. Vaccine. 2013;32(1):74–77. doi:10.1016/j.vaccine.2013.10.067.
   PubMed Web of Science ®Google Scholar
• Wang CL, Zhang XW, Yu YX. Study on the compliance and economic cost of rabies vaccination. Chin J Vacc Immunization. 2010;16(3):254–57.
   Google Scholar
• Peng J, Chen L, Zhu Z, Zhu Z, Hu Q, Fang Y. Effect of Corticosteroids on RVNA production of a patient with acute disseminated encephalomyelitis following rabies vaccination as well as administration of HRIG. Hum Vacc Immunother. 2015;10(12):3622–26. doi:10.4161/21645515.2014.979621.
   Web of Science ®Google Scholar
• Fang Y, Liu M, Chen L, Zhu Z, Zhu Z, Hu Q. Rabies post-exposure prophylaxis for a child with severe allergic reaction to rabies vaccine. Hum Vacc Immunother. 2016;12(7):1802–04.
   PubMed Web of Science ®Google Scholar
• Zhu ZG, Zheng Y, Lu S, Hu Q, Fang Y. Rabies post-exposure prophylaxis for a male with severe Henoch Schonlein purpura following rabies vaccination. Hum Vaccin Immunother. 2018;14(11):2666–68. doi:10.1080/21645515.2018.1486354.
   PubMed Web of Science ®Google Scholar
• Huang S, Zhu Z, Cai L, Zhu Z, Zhang M, Hu Q, Fang Y. Analysis on the risks of severe adverse events in rabies post-exposure prophylaxis and appropriate decision-making procedure. Hum Vacc Immunother. 2018;15(9):2121–25. doi:10.1080/21645515.2018.1533779.
   PubMed Web of Science ®Google Scholar
• Hu Q, Liu M, Zhu Z, Zhu Z, Lu S. Comparison of safety and immunogenicity of purified chick embryo cell vaccine using Zagreb and Essen regimens in patients with category II exposure in China. Hum Vacc Immunother. 2014;10(6):1645–49. doi:10.4161/hv.28420.
   PubMed Web of Science ®Google Scholar
• Li R, Li Y, Wen S, Wen H, Nong Y, Mo Z, Xie F, Pellegrini M. Immunogenicity and safety of purified chick-embryo cell rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese children 6 to 17 years old and adults over 50 years: a randomized open-label study. Hum Vaccin Immunother. 2015;11(2):435–42. doi:10.4161/21645515.2014.994460.
   PubMed Web of Science ®Google Scholar
• Ma J, Wang H, Li J, Chang L, Xie Y, Liu Z, Zhao Y, Claudius M. A randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the Zagreb regimen (2-1-1) compared with the Essen regimen in Chinese adults. Hum Vaccin Immunother. 2014;10(10):2805–12. doi:10.4161/21645515.2014.972773.
   PubMed Web of Science ®Google Scholar
• Mahendra BJ, Narayana DA, Agarkhedkar S, Ravish HS, Harish BR, Agarkhedkar S, Madhusudana SN, Belludi A, Ahmed K, Jonnalagedda R, et al. Comparative study on the immunogenicity and safety of a purified chick embryo cell rabies vaccine (PCECV) administered according to two different simulated post exposure intramuscular regimens (Zagreb versus Essen). Hum Vaccin Immunother. 2015;11(2):428–34. doi:10.4161/21645515.2014.995059.
   PubMed Web of Science ®Google Scholar
• Chineses Pharmacopoeia Commission. Pharmacopoeia of people’s Republic of China. Beijing: China Medical Science and Technology Press; 2010.
   Google Scholar
• Zhang X, Zhu Z, Wang C. Persistence of rabies antibody 5 years after postexposure prophylaxis with vero cell antirabies vaccine and antibody response to a single booster dose. Clin Vaccine Immunol. 2011;18(9):1477–79. doi:10.1128/CVI.05090-11.
   PubMedGoogle Scholar